GLG News by Physicians who Treat Neuropathy (US)

Newer, more efficacious antiretrovirals are emerging.Older treatments  must be open in order to be competitive and continue in the market.

Ideal treatment of Multiple Sclerosis is still ongoing. Interferons are only partially succesful in treating this condition. Alemtuzumab, a drug that was intended for the treatment of B-cell chronic lymphocytic leukemia proved to be useful in MS. It reduced significantly the risk  of relapse and...

Thiazolidinedione induced weight gain is mitigated with the addition of Exenatide, while improving glycemic control in Type 2 diabetes

Bariatric Surgery works to treat diabetes in the short run, but it is expensive and dangerous.

Slight weight loss is demonstrated in a large observational study. This seems to support smaller studies. However, this is not a main advantage of Levemir.

Rebooting the immune system represents a new avenue to explore, but its very early in the process.

This article confirms what many of us had expected.  Enenatide works, as predicted, with a TZD with comparable reductions in A1c to other settings.  Many physicians had been previously using the combination "off label"  The study allowed the label to be modified to include the combination,...

Old technology, limited usefulness More expensive than vials

Dosing frequency is a small part of the success mix.

Metformin should be in the PCOS mix.